Pyrazinoindoles

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/495 (2006.01)

Patent

CA 2097465

The novel pyrazinoindoles of the general formula Image I wherein R1 signifies hydrogen, halogen, trifluoromethyl, lower alkyl, hydroxy or lower alkoxy, R2 signifies hydrogen or halogen and R3 signifies hydrogen, lower alkoxy or lower alkylthio, with the proviso that R3 can only signify hydrogen when R1 and R2 are both different from hydrogen, and pharmaceutically acceptable acid addition salts of the compounds of formula I are suitable for the treatment or prophylaxis of central nervous disorders such as depression, bipolar disorders, anxiety, sleep and sexual disorders, psychosis, schizophrenia, migraine and other conditions associated with cephalic pain or other pain types, personality disorders and obsessive-compulsive disorders, social phobia or panic disorders, mental organic disorders, mental disorders in childhood, aggressiveness, age-associated memory impairement and behavioral symptoms, addiction, obesity, bulimia etc.; neural damage resulting from trauma, stroke, neurodegenerative diseases etc.; cardiovascular disorders such as hypertension, thrombosis, stroke etc.; and gastrointestinal disorders such as dysfunction of gastrointestinal tract motility.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pyrazinoindoles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazinoindoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazinoindoles will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1563681

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.